-
公开(公告)号：KR1020090064702A
公开(公告)日：2009-06-22
申请号：KR1020070131999
申请日：2007-12-17
Applicant: 강화군
IPC: A61K31/4045 , A61K31/404 , A61K36/31 , A61P9/02
CPC classification number: A61K31/404 , A61K36/31
Abstract: A pharmaceutical composition containing Brassica rapa extracts is provided to prevent and treat kidney toxicity diseases by cisplatin and cardiac circulation disease by LDL oxidation. A pharmaceutical composition for preventing and treating kidney toxicity diseases which is caused by an anticancer drug comprises 0.01-98 weight% of 4-methoxyindole-3-acetonitrile as an active ingredient. The 4-methoxyindole-3-acetonitrile is isolated from a Brassica rapa. An anticancer adjuvant having suppression activity to kidney toxicity comprises the 4-methoxyindole-3-acetonitrile. A pharmaceutical composition for preventing and treating cardiac circulation diseases comprises the 4-methoxyindole-3-acetonitrile as an active ingredient. The cardiac circulation diseases are hyperlipidemia, cerebral artery, coronary heart disease, arteriosclerosis or myocardial infarction.
Abstract translation: 提供含有芸苔属提取物的药物组合物，通过LDL氧化预防和治疗顺铂和心脏循环疾病的肾脏毒性疾病。 用于预防和治疗由抗癌药物引起的肾毒性疾病的药物组合物包含0.01-98重量％的4-甲氧基吲哚-3-乙腈作为活性成分。 从芸苔属油菜中分离4-甲氧基吲哚-3-乙腈。 对肾毒性具有抑制活性的抗癌佐剂包括4-甲氧基吲哚-3-乙腈。 用于预防和治疗心脏循环疾病的药物组合物包含4-甲氧基吲哚-3-乙腈作为活性成分。 心脏循环疾病是高脂血症，脑动脉，冠心病，动脉硬化或心肌梗死。
-
公开(公告)号：KR101184100B1
公开(公告)日：2012-09-18
申请号：KR1020100054460
申请日：2010-06-09
Applicant: 강화군
Abstract: 본 발명은 약쑥맥주 및 이의 제조방법에 관한 것으로, 구체적으로는 맥아를 당화시킨 후 강화약쑥 및 호프를 첨가하여 자비시키는 단계를 포함하는 약쑥맥주 및 이의 제조방법에 관한 것이다. 본 발명의 약쑥 함유 맥주는 맛과 향에 있어서 우수하여 제품의 품질이 높을 뿐만 아니라 원료인 강화약쑥의 약리효능을 최대한 이끌어내어 음용자의 건강에 유익하며 특히 강화약쑥에 주로 함유되어 있는 유파틸린 및 자세오시딘에 의한 간장 보호효과에 의해 음주로 인한 간 손상을 막아주며 숙취해소에 도움이 된다. 또한 본 발명의 제조방법은 발효방식 제한 및 약쑥 첨가 시기 조절을 통해 약쑥 첨가로 인해 강해지는 쓴 맛을 조절하고, 목넘김을 개선하여 기호도가 우수한 약쑥맥주를 제조할 수 있다.
-
公开(公告)号：KR1020120089906A
公开(公告)日：2012-08-16
申请号：KR1020100131320
申请日：2010-12-21
Applicant: 강화군
Abstract: PURPOSE: A composition containing a fraction of Brassica campestris spp. rappa alcohol extract is provided to ensure anti-obesity effect. CONSTITUTION: A composition for anti-obesity contains a fraction which is prepared by fractioning Brassica campestris spp. rappa alcohol extract with hexane and ethyl acetate mixture. The alcohol is low alcohol of 1-4 carbon atoms. The composition is a food composition or pharmaceutical composition. The food composition is manufactured in the form of a tablet, granule, powder, beverage, and gruel.
Abstract translation: 目的：一种含有一些芥菜油菜的组合物。 提供拉巴醇提取物以确保抗肥胖效果。 构成：用于抗肥胖的组合物含有通过将芥菜油菜分馏而制备的级分。 拉巴醇提取物与己烷和乙酸乙酯混合。 醇是1-4个碳原子的低级醇。 组合物是食品组合物或药物组合物。 食品组合物以片剂，颗粒剂，粉末，饮料和稀释剂的形式制造。
-
公开(公告)号：KR1020110134724A
公开(公告)日：2011-12-15
申请号：KR1020100054460
申请日：2010-06-09
Applicant: 강화군
Abstract: PURPOSE: A method for manufacturing beer containing Artemisia princeps Pampanini cv. is provided to prevent liver damage and to relieve hangover. CONSTITUTION: A method for manufacturing beer containing Artemisia princeps Pampanini cv. comprises: a step of dipping malt into water; a step of liquefying and saccharifying to prepare a solution; a step of adding Artemisia princeps Pampanini cv. and hop into the solution; a step of adding Artemisia princeps Pampanini cv.; a step of filtering the solution to prepare saccharified liquid; a step of adding yeast to the saccharified liquid for prefermentation; and a step of performing post-fermentation.
Abstract translation: 目的：制造含有艾蒿罂粟碱的啤酒的方法。 是为了防止肝损伤和缓解宿醉。 构成：一种制造含有青蒿罂粟碱的啤酒的方法。 包括：将麦芽浸入水中的步骤; 液化和糖化以制备溶液的步骤; 添加艾蒿罂粟花的步骤 进入解决方案; 添加艾蒿罂粟花的步骤。 过滤溶液以制备糖化液体的步骤; 将酵母添加到糖化液中进行优选的步骤; 以及进行后发酵的步骤。
-
公开(公告)号：KR100949011B1
公开(公告)日：2010-03-23
申请号：KR1020090080306
申请日：2009-08-28
Applicant: 강화군
IPC: A61K31/34 , A61K36/282 , A61P3/06 , A61P9/10
Abstract: 본 발명은 사자발쑥 추출물을 포함하는 약학 조성물에 관한 것으로, 특히 사자발쑥 추출물 중 3β,4β-에폭시-8α-이소부티릴옥시구아이아-1(10),11(13)-디엔-12,6α-올라이드를 유효성분으로 포함하여 심장순환계 질환의 예방 및 치료에 효과적인 약학 조성물에 관한 것이다.
3β,4β-에폭시-8α-이소부티릴옥시구아이아-1(10),11(13)-디엔-12,6α-올라이드, 사자발쑥, 동맥경화, 고지혈증Abstract translation: 本发明涉及药物组合物，特别是3β，4β-环氧-8α-异丁氧基sajabal艾蒿提取物AH-1岁儿童（10），其包括sajabal艾蒿提取物，11（13） - 二烯-12， 6α-内酯为有效成分，对心血管疾病的预防和治疗有效。
-
Patent Agency Ranking
公开(公告)号：KR1020090064692A
公开(公告)日：2009-06-22
申请号：KR1020070131982
申请日：2007-12-17
Applicant: 강화군
IPC: A61K31/352 , A61K36/282 , A61P35/00
Abstract: A pharmaceutical composition containing an Artemisia princeps extract is provided to prevent and treat cancer and cardiac circulation disease by the effects of strong cytotoxicity and antioxidation activity. A composition for preventing and treating cancer comprises a 3beta,4beta-epoxy-8a-isobutyryloxyguaia-1(10),11(13)-diene-12.6a-olide as an active ingredient. The 3beta,4beta-epoxy-8a-isobutyryloxyguaia-1(10),11(13)-diene-12.6a-olide is isolated from an Artemisia princeps. The 3beta,4beta-epoxy-8a-isobutyryloxyguaia-1(10),11(13)-diene-12.6a-olide is contained in a ratio of 0.01-94 weight%. The cancer is ovarian cancer or leukemia.
Abstract translation: 提供含有青蒿提取物的药物组合物，以通过强的细胞毒性和抗氧化活性的作用预防和治疗癌症和心脏循环疾病。 用于预防和治疗癌症的组合物包含作为活性成分的3β，4β-环氧-8a-异丁酰氧基瓜亚-1（10），11（13） - 二烯-12.6a-olide。 从艾蒿中分离出3β，4β-环氧-8a-异丁酰氧基瓜亚-1（10），11（13） - 二烯-12.6a-olide。 3β，4β-环氧-8a-异丁酰氧基瓜亚-1（10），11（13） - 二烯-12.6a-olide的含量为0.01-94重量％。 癌症是卵巢癌或白血病。
-
17.发明公开
公开(公告)号：KR1020100076614A
公开(公告)日：2010-07-06
申请号：KR1020080134726
申请日：2008-12-26
Applicant: 강화군
IPC: A61K31/343 , A61K36/282 , A61P35/00
Abstract: PURPOSE: A composition containing eupafolin isolated from Artemisia princeps Pampanini is provided to suppress proliferation of cancer cells by inducing cancer cell apoptosis. CONSTITUTION: A pharmaceutical composition for preventing and treating cancer contains eupafolin of structural formula 1 as an active ingredient, which is isolated from Artemisia princeps Pampanini. The composition contains 0.1-50 weight% of Artemisia princeps Pampanini extract. The Artemisia princeps Pampanini extract is isolated using water, low alcohol of C1-C4, or mixture solvent thereof. A health food for preventing and treating cancer contains eupafolin as an active ingredient. The health food is used in the form of powder, granule, tablet, capsule, or beverage.
Abstract translation: 目的：通过诱导癌细胞凋亡，提供含有从艾蒿罂粟碱分离出来的紫花苜蓿的组合物。 构成：用于预防和治疗癌症的药物组合物含有结构式1的作为活性成分的卵白蛋白，其从艾蒿罂粟花中分离出来。 该组合物含有0.1-50重量％的蒿蒿提取物。 使用水，C1-C4的低级醇或其混合溶剂分离青蒿茯苓提取物。 用于预防和治疗癌症的保健食品含有作为活性成分的香叶酚。 保健食品以粉末，颗粒，片剂，胶囊或饮料的形式使用。
-
公开(公告)号：KR100949001B1
公开(公告)日：2010-03-23
申请号：KR1020070131999
申请日：2007-12-17
Applicant: 강화군
IPC: A61K31/4045 , A61K31/404 , A61K36/31 , A61P9/02
Abstract: 본 발명은 순무 추출물을 포함하는 약학 조성물에 관한 것으로, 특히 순무로부터 추출한 4-메톡시인돌-3-아세토니트릴(4-methoxyindole-3-acetonitrile)을 유효성분으로 포함하여 항암제에 의해 유발되는 신장 독성 질환뿐 아니라 심장순환계 질환의 예방 및 치료용 약학 조성물에 관한 것이다.
4-메톡시인돌-3-아세토니트릴, 순무, 시스플라틴, 신장 독성, 항암제, 심장순환계 질환-
公开(公告)号：KR1020090107005A
公开(公告)日：2009-10-12
申请号：KR1020090080306
申请日：2009-08-28
Applicant: 강화군
IPC: A61K31/34 , A61K36/282 , A61P3/06 , A61P9/10
Abstract: PURPOSE: A pharmaceutical composition containing Artemisia princeps pampanini extract is provided to ensure anti-oxidative activity and prevent and treat heart circulatory diseases such as hyperlipidemia, coronary artery, arteriosclerosis, and myocardial infarction. CONSTITUTION: A pharmaceutical composition for preventing and treating heart circulatory diseases contains 3β,4β-epoxy-8α-isobutyryloxyguaia-1(10),11(13)-diene-12,6α-olide of the chemical formula 1 as an active ingredient. The 3β,4β-epoxy-8α-isobutyryloxyguaia-1(10),11(13)-diene-12,6α-olide is obtained by extracting Artemisia princeps pampanini using low alcohol of C1-C4, desirably methanol solution, and performing fraction.
Abstract translation: 目的：提供含有青蒿提取物的药物组合物，以确保抗氧化活性，预防和治疗心脏循环系统疾病如高脂血症，冠状动脉，动脉硬化和心肌梗塞。 构成：用于预防和治疗心脏循环系统疾病的药物组合物含有化学式1的3β，4β-环氧-8α-异丁酰氧基瓜亚-1（10），11（13） - 二烯-12,6α-二醇作为活性成分。 通过使用C1-C4的低醇，优选甲醇溶液提取青蒿提取青蒿素获得3β，4β-环氧-8α-异丁酰氧基瓜亚胺（10），11（13） - 二烯-12,6α- 。
-
公开(公告)号：KR1020090064712A
公开(公告)日：2009-06-22
申请号：KR1020070132014
申请日：2007-12-17
Applicant: 강화군
IPC: A61K31/352 , A61K36/282
Abstract: A pharmaceutical composition containing Artemisia herba extract for preventing and treating cardiac circulation diseases is provided to prevent and treat hyperlipidemia, cerebral artery, coronary heart disease, arteriosclerosis, and myocardial infarction caused by LDL oxidation. A pharmaceutical composition for preventing and treating cardiac circulation diseases comprises an ergosterol peroxide as an active ingredient. The ergosterol peroxide is isolated from an Artemisia herba. The ergosterol peroxide is contained in a ratio of 0.01-96 weight% based on the total weight. The cardiac circulation diseases are hyperlipidemia, cerebral artery, coronary heart disease, arteriosclerosis or myocardial infarction.
Abstract translation: 本发明提供含有艾蒿提取物，用于预防和治疗心脏循环疾病的药物组合物，用于预防和治疗由LDL氧化引起的高脂血症，脑动脉，冠心病，动脉硬化和心肌梗死。 用于预防和治疗心脏循环疾病的药物组合物包括麦角甾醇过氧化物作为活性成分。 麦角甾醇过氧化物从艾蒿中分离出来。 麦角甾醇过氧化物的含量占总重量的0.01-96重量％。 心脏循环疾病是高脂血症，脑动脉，冠心病，动脉硬化或心肌梗死。
-
-
-
-
-
-
-
-
-
Search Results
29
records
(took 0.023 seconds)
